Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.59 +0.10 (+1.05%)
At close: Nov 11, 2026 · 4:00 PM EST

Syndax Pharmaceuticals (SNDX) Change in Accrued Expenses (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Change in Accrued Expenses of $21.27 million in Q3 2026, compared with $1.1 million a year earlier and up 13.3% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Change in Accrued Expenses (2015 - 2026) Analysis & Trends

On a TTM basis, Syndax Pharmaceuticals' Change in Accrued Expenses came in at $37.39 million as of Sep 30, 2026, up 32.9% year-over-year; for FY2025, it was $42.17 million, up 120.3% from FY2024.

  • Annual Change in Accrued Expenses has increased for five straight years, with a five-year compound annual growth rate of 136.7% (FY2020 to FY2025).
  • Across earlier years, Change in Accrued Expenses came in at $19.14 million in FY2024 (+28.7%), $14.87 million in FY2023 (+57.8%), $9.42 million in FY2022 (+240.2%) and $2.77 million in FY2021 (+388.4%).
  • Quarterly Change in Accrued Expenses has ranged from -$28.35 million in Q1 2026 to $25.7 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Change in Accrued Expenses rose in three of the last four quarters, with growth averaging 21.5%.
  • Per Business Quant, the preceding three quarters came in at $18.77 million (Q2 2026), -$28.35 million (Q1 2026) and $25.7 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn 21.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21.27 Mn
Jun 30, 2026 18.77 Mn
Mar 31, 2026 -28.35 Mn
Dec 31, 2025 25.70 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 17.90 Mn
Mar 31, 2025 -2.53 Mn
Dec 31, 2024 11.66 Mn
Sep 30, 2024 21.04 Mn
Jun 30, 2024 -6.84 Mn
Mar 31, 2024 -6.71 Mn
Dec 31, 2023 7.50 Mn
Sep 30, 2023 14.16 Mn
Jun 30, 2023 2.38 Mn
Mar 31, 2023 -9.17 Mn
Dec 31, 2022 10.97 Mn
Sep 30, 2022 -3.86 Mn
Jun 30, 2022 -1.54 Mn
Mar 31, 2022 3.86 Mn
Dec 31, 2021 638,000.00
API Access

Syndax Pharmaceuticals Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SNDX&period=max&api_key=YOUR_API_KEY